![]() Casma Therapeutics Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines. | ![]() Sonoma BioTherapeutics Sonoma BioTherapeutics is a company that develops a regulatory T-cell therapy for autoimmune and degenerative diseases. | ![]() OliPass Corporation OliPass Corporation (previously known as CTI-Bio) is a biotech company focused on healthy aging. | ![]() Isomerase Isomerase is a company that provides biotechnology drug discovery and development services exploiting microbial natural products. | ||
Founding Date | Founding Date 2014 | Founding Date 2018 | Founding Date 2019 | Founding Date 2006 | Founding Date 2012 |
Type | Type Private | Type Private | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Needham, US HQ | Locations Cambridge, US HQ | Locations South San Francisco, US HQ Seattle, US | Locations Yongin-si, KR HQ Suwon, KR | Locations Little Chesterford, GB HQ |
Employees | Employees 4 | Employees 1225% decrease | Employees 1153% decrease | Employees 78 | Employees 343% decrease |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 50m (over 5 years ago) | Latest funding round $ 30m (over 5 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 108.5m | Total funding raised $ 70m | Total funding raised $ 18.4m | Total funding raised N/A |

Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.
View company
Sonoma BioTherapeutics is a company that develops a regulatory T-cell therapy for autoimmune and degenerative diseases.
View company
OliPass Corporation (previously known as CTI-Bio) is a biotech company focused on healthy aging.
View company
Isomerase is a company that provides biotechnology drug discovery and development services exploiting microbial natural products.
View company